Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESSO 43 | Highlighting metastasis as a mainstream focus in surgical oncology

Ignace H.J.T. de Hingh • 2 Oct 2024
ESSO 43
General

Ignace H.J.T. de Hingh, MD, PhD, Catharina Cancer Institute, Eindhoven, Netherlands, expresses enthusiasm about the growing focus on metastasis at major conferences like ESSO 43, noting that it is increasingly being addressed by a diverse group of experts. He reflects on how this topic, once considered rare, is now becoming a mainstream aspect of surgical oncology, which he hopes will inspire young researchers to contribute to the field. This interview took place at the ESSO 43 congress in Antwerp, Belgium.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Ignace H.J.T. de Hingh

Debating CRS and HIPEC for colorectal peritoneal metastasis
0:47
Debating CRS and HIPEC for colorectal peritoneal metastasis
Ignace H.J.T. de Hingh • 2 Oct 2024
Challenges and benefits of systemic chemotherapy for peritoneal metastasis
0:54
Challenges and benefits of systemic chemotherapy for peritoneal metastasis
Ignace H.J.T. de Hingh • 2 Oct 2024
Optimizing neoadjuvant and adjuvant therapy for patients undergoing CRS and HIPEC
0:38
Optimizing neoadjuvant and adjuvant therapy for patients undergoing CRS and HIPEC
Ignace H.J.T. de Hingh • 2 Oct 2024
Debating the role of adjuvant HIPEC after cancer surgery
1:03
Debating the role of adjuvant HIPEC after cancer surgery
Ignace H.J.T. de Hingh • 2 Oct 2024

Related Videos

Quality gaps in online patient information about AI in cancer care
1:24
Quality gaps in online patient information about AI in cancer care
Eleonora Teplinsky • 31 May 2026
Educating patients on AI risks and misinformation in cancer care
1:36
Educating patients on AI risks and misinformation in cancer care
Eleonora Teplinsky • 31 May 2026
Educational impact of a guideline-based hematology-oncology bootcamp curriculum
2:41
Educational impact of a guideline-based hematology-oncology bootcamp curriculum
Chinmay Jani • 31 May 2026
Reduced-dose radiation achieves local control in ATM-mutated cancers: Phase II results
1:26
Reduced-dose radiation achieves local control in ATM-mutated cancers: Phase II results
Amy Xu • 31 May 2026
The content of VJOncology is intended for healthcare professionals